Your browser doesn't support javascript.
loading
An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1.
Deng, Haibin; Ge, Huixiang; Dubey, Christelle; Losmanova, Tereza; Medová, Michaela; Konstantinidou, Georgia; Mutlu, Seyran Mathilde; Birrer, Fabienne Esther; Brodie, Tess Melinda; Stroka, Deborah; Wang, Wenxiang; Peng, Ren-Wang; Dorn, Patrick; Marti, Thomas Michael.
Afiliación
  • Deng H; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.
  • Ge H; Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Dubey C; Thoracic Surgery Department 2, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.
  • Losmanova T; Hunan Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.
  • Medová M; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.
  • Konstantinidou G; Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Mutlu SM; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
  • Birrer FE; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.
  • Brodie TM; Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Stroka D; Institute of Pathology, University of Bern, Bern, Switzerland.
  • Wang W; Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Peng RW; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Dorn P; Institute of Pharmacology, University of Bern, Bern, Switzerland.
  • Marti TM; Department for BioMedical Research, University of Bern, Bern, Switzerland.
Cancer Immunol Immunother ; 72(12): 4457-4470, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37796299
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Guideline / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Guideline / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Suiza